Have a personal or library account? Click to login
Cervix-Online computer program: 27 years of hospital-based clinical registry for cervical cancer at the University Medical Centre Maribor Cover

Cervix-Online computer program: 27 years of hospital-based clinical registry for cervical cancer at the University Medical Centre Maribor

Radiology and Oncology
Volume 56 (2022): Issue 2 (June 2022)
By:
Open Access
|Dec 2021

Figures & Tables

Figure 1

General data. CT = chemotherapy; RT = radiotherapy
General data. CT = chemotherapy; RT = radiotherapy

Figure 2

Medical history, clinical examination, clinical stage (preoperative International Federation of Gynecology and Obstetrics [FIGO] stage). AGC - neoplastic = atypical glandular cells - neoplastic; AGC-NOS = atypical glandular cells - not otherwise specified; AIS = adenocarcinoma in situ; AC = adenocarcinoma; ASC-US = atypical squamous cells - of undetermined significance; ASC-H = atypical squamous cells - cannot exclude HSIL; GIT = gastrointestinal tract; HGSIL = high grade squamous intraepithelial lesion; IUD = intrauterine device; IUS = intrauterine system; LGSIL = low grade squamous intraepithelial lesion; MLG-N = other malignant cells - inevaluable; MTOP = medical termination of pregnancy; N/A = not available; SCC = squamous cell carcinoma; SFM-NOS = suspicious for malignancy - not otherwise specified
Medical history, clinical examination, clinical stage (preoperative International Federation of Gynecology and Obstetrics [FIGO] stage). AGC - neoplastic = atypical glandular cells - neoplastic; AGC-NOS = atypical glandular cells - not otherwise specified; AIS = adenocarcinoma in situ; AC = adenocarcinoma; ASC-US = atypical squamous cells - of undetermined significance; ASC-H = atypical squamous cells - cannot exclude HSIL; GIT = gastrointestinal tract; HGSIL = high grade squamous intraepithelial lesion; IUD = intrauterine device; IUS = intrauterine system; LGSIL = low grade squamous intraepithelial lesion; MLG-N = other malignant cells - inevaluable; MTOP = medical termination of pregnancy; N/A = not available; SCC = squamous cell carcinoma; SFM-NOS = suspicious for malignancy - not otherwise specified

Figure 3

Tests at initial examination. CEA = carcinoembryonic antigen; L = left; NAD = no evidence of disease; R = right; SCC = squamous cell carcinoma antigen
Tests at initial examination. CEA = carcinoembryonic antigen; L = left; NAD = no evidence of disease; R = right; SCC = squamous cell carcinoma antigen

Figure 4

Treatment. CT = chemotherapy: DVT = deep vein thrombosis; G-CSF = granulocyte colony stimulating factor
Treatment. CT = chemotherapy: DVT = deep vein thrombosis; G-CSF = granulocyte colony stimulating factor

Figure 5

Histopathology, International Federation of Gynecology and Obstetrics (FIGO) stage after definitive histology. L = left; R = right
Histopathology, International Federation of Gynecology and Obstetrics (FIGO) stage after definitive histology. L = left; R = right

Figure 6

Chemotherapy cycles. CEA = carcinoembryonic antigen; G-CSF = granulocyte colony stimulating factor; NAD = nothing abnormal detected; SCC = squamous cell carcinoma antigen
Chemotherapy cycles. CEA = carcinoembryonic antigen; G-CSF = granulocyte colony stimulating factor; NAD = nothing abnormal detected; SCC = squamous cell carcinoma antigen

Figure 7

Follow-up form. TH = therapy; NAD = nothing abnormal detected; ASC-US = atypical squamous cells of undetermined significance; ASC-H = atypical squamous cells – cannot exclude HSIL; LGSIL = low-grade squamous intraepithelial lesion ; HGSIL = high grade squamous intraepithelial lesion; SCC = squamous cell carcinoma; AGC-NOS = atypical glandular cells not otherwise specified; AGC-neoplastic = atypical glandular cells, suspicious for AIS or cancer; AIS = adenocarcinoma in situ; AC = adenocarcinoma; SFM-NOS = suspicious for malignancy; MLG-N = malignancy; SCC = squamous cell carcinoma antigen; CEA = carcinoembryonic antigen; UTI = urinary tract infection
Follow-up form. TH = therapy; NAD = nothing abnormal detected; ASC-US = atypical squamous cells of undetermined significance; ASC-H = atypical squamous cells – cannot exclude HSIL; LGSIL = low-grade squamous intraepithelial lesion ; HGSIL = high grade squamous intraepithelial lesion; SCC = squamous cell carcinoma; AGC-NOS = atypical glandular cells not otherwise specified; AGC-neoplastic = atypical glandular cells, suspicious for AIS or cancer; AIS = adenocarcinoma in situ; AC = adenocarcinoma; SFM-NOS = suspicious for malignancy; MLG-N = malignancy; SCC = squamous cell carcinoma antigen; CEA = carcinoembryonic antigen; UTI = urinary tract infection
DOI: https://doi.org/10.2478/raon-2021-0054 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 198 - 207
Submitted on: Sep 13, 2021
Accepted on: Nov 22, 2021
Published on: Dec 22, 2021
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
hospital-based clinical registry,
computer program,
cervical cancer
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2021 Vida Gavric Lovrec, Darja Arko, Iztok Takac, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 56 (2022): Issue 2 (June 2022)Next article